AbbVie (ABBV) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist

171.090
-3.340-1.91%

Close Nov 12 16:00 ET

171.740
+0.650+0.38%

Post 20:01 ET

302.34BMarket Cap59.61P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

UBS Maintains AbbVie(ABBV.US) With Hold Rating, Cuts Target Price to $181
Moomoo News14:32 ET · Ratings
AbbVie Is Maintained at Buy by Citigroup
Dow Jones14:08 ET · Ratings
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
Benzinga13:52 ET
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Benzinga12:48 ET
AbbVie's Loss Is Bristol Myers Squibb's Gain - Analyst | NYSE:ABBV
Proactive Investors11:33 ET
Tuesday Market Finally Slows Down, Takes a Post Veterans Day Breather | Live Stock
Kevin Travers11:17 ET

Comments

DimondHandsDsolo94

$AbbVie (ABBV.US)$ for the who don't know they failed a drug test or something but they will make a come back next year 165 let's goooo

1

DimondHandsDsolo94

$AbbVie (ABBV.US)$ 165 lets gooooo#Bearish

Yesterday 05:20

Columns Triple Treat Monday Sees Indecies Hit High Closes | Wall Street Today

Happy Monday, November 11th. The market climbed to a trifecta of closing highs for indices. The S&P 500 broke through 6k Friday and traded above the historic mark again Monday before the market pulled back in the afternoon.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +10 bps, the $Dow Jones Industrial Average (.DJI.US)$ climbed 69 bps, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.06%.
MACRO
In macroecon...

Triple Treat Monday Sees Indecies Hit High Closes | Wall Street Today

Triple Treat Monday Sees Indecies Hit High Closes | Wall Street Today

Bitcoin repeatedly nears $90,000 in one day! How close is $100,000?

44

10

Yesterday 00:44

$AbbVie (ABBV.US)$
buy little to play play laaa dont say bo jio

2

$AbbVie (ABBV.US)$ good to enter a little

1

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data